Reduce Live Study Risk With AI in eClinical Workflows

AI is entering live clinical trials. Are your workflows ready?

Date: Wednesday, August 26, 2026

Time: 11am EDT · 4pm BST · 5pm CEST

Duration: 60 minutes

Sponsors, CROs, and sites are generating more data than ever from EDC, eCOA, RTSM, labs, wearables, imaging, and safety systems. Manual review models are under pressure as data volumes rise and timelines compress. This webinar explores how AI is being applied in live studies right now, and how to adopt it without disrupting ongoing trials.

What You Will Learn

  • What AI is actually doing in live eClinical studies today, across EDC, eCOA, RTSM, labs and safety systems, and where it is reducing real risk
  • Validating and documenting AI-assisted workflows to satisfy regulators and sponsors without disrupting active trials
  • What meaningful human oversight looks like in practice, and how to build governance that keeps pace with implementation
  • Concrete steps to build AI readiness across CDM and clinical operations teams starting now

Speakers

Joby John, Vice President, Service Delivery, Sitero
Senior clinical research leader with over 20 years of global experience across pharma, CROs, and FSPs. Oversees professional and managed services for Sitero’s Mentor eClinical platform, including EDC, CDM, and Biostatistics. Has presented and chaired sessions at DIA and SCDM.

Aman Thukral, Head of Digital Operations and Clinical Systems, AbbVie
19 years of experience in clinical development and technology planning. Responsible for AbbVie’s Clinical Data Repository, eCOA operations, wearables, sensors, and new technology pilots. Previously at Deloitte, Cognizant, and GlaxoSmithKline.

Angela N. Johnson, PhD, RAC, Senior Vice President, Advisory Services, Avania
As Senior Vice President of Advisory Services at Avania, Dr. Johnson oversees the firm’s engineering and product development offerings as well as strategic services supporting clinical development, including regulatory, market access and reimbursement, and digital health and AI consulting. She has over 25 years of experience in clinical operations and regulatory leadership in GxP settings spanning GCP and GMP across devices, diagnostics, biologics, and combination products. At GE Healthcare she managed global clinical affairs operations for the Global Research Organization, expanding the digital footprint of data management, biostatistics, medical writing, and monitoring. In addition to deep work in AI-enabled synthetic imaging that received the Lucien Levy Award from the American Journal of Neuroradiology, she has contributed to multiple open source and nonprofit AI projects and has been an invited speaker on clinical AI at events including the 2026 AI Agent Conference in New York. Prior to Avania, Dr. Johnson held global regulatory leadership roles at Cytiva (Danaher) and multiple venture-backed firms. She teaches FDA regulatory strategy at Northeastern University.

Who Should Attend

  • Clinical Data Management and Data Operations leaders
  • Clinical Operations and Study Management professionals

  • Quality Assurance and GCP Compliance teams

  • eClinical Systems and Technology Leads
  • Sponsor and CRO leadership overseeing CDM and Clinical Operations
  • Biometrics, Biostatistics, and Programming teams
  • Anyone evaluating, implementing, or governing AI and automation tools in clinical trials